case / 25 Jun 2018

Setterwalls has assisted Recipharm in connection with directed share issue of approximately SEK 508 million

Responsive image

Setterwalls has assisted Recipharm AB (publ) in connection with a directed share issue to a number of Swedish and international institutional investors.

The gross proceeds of the share issue amounts to approximately SEK 508 million. Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing around 5,000 employees. For further information about the share issue and Recipharm, please refer to the company’s website.

Do you want to get in touch with us?

Please fill out the form and we will contact you as soon as possible.

  • This field is for validation purposes and should be left unchanged.